[XENE] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 11.76%
YoY- -28.28%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 536 2,218 13,384 0 0 15 413 4.43%
PBT -31,198 -22,326 -214 -10,036 -7,801 -7,380 -6,016 31.54%
Tax -40 -217 -39 -29 200 -513 -350 -30.32%
NP -31,158 -22,109 -175 -10,007 -7,801 -7,380 -6,016 31.51%
Tax Rate - - - - - - - -
Total Cost 31,694 24,327 13,559 10,007 7,801 7,395 6,429 30.44%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -5,813.06 -996.80 -1.31 0.00 0.00 -49,200.00 -1,456.66 25.92%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.55 -0.53 -0.01 -0.39 -0.55 -0.41 -0.42 4.59%
EPS Diluted -0.55 -0.53 -0.01 -0.39 -0.55 -0.41 -0.42 4.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.